Abstracts tagged "caregivers"

Abstract Number: 1842 • 2019 ACR/ARP Annual Meeting
Patients and Relatives Coping with Inflammatory Arthritis: Impact of Communication, Social Support and Relatives Burden on Patients Perceived Health
Morgane Brignon ¹, Catherine Beauvais ², Martine Beranger ³, Jean-David Cohen ⁴, Isabelle Griffoul ⁵, Janine Sophie Le Quintrec ⁶, Didier Poivret ⁷, Corinne Thevenot ⁸, Sonia Trope ⁹ and Anne-Christine Rat¹⁰, ¹Université de Lorraine, EA 4360 APEMAC, Nancy, France, ²Saint-Antoine Hospital, Hôpitaux universitaires Est Parisien, AP–HP, Paris, France, ³Orléans Hospital, Orléans, France, ⁴Montpellier University hospital, Montpellier, France, ⁵Tours University Hospital, Tours, France, ⁶Cochin University Hospital, Paris, France, ⁷Metz Hospital, Metz, France, ⁸Laon Hospital, Laon, France, ⁹Andar, Montpellier, France, ¹⁰CHU Caen, rheumatology department, Caen Normandie University, Université de Lorraine, EA 4360 APEMAC, Caen, France
Background/Purpose: Relatives’ and patients’ adjustment to a chronic disease is complex, and there is room for improvement in the support provided to the dyad. So…
Abstract Number: 594 • 2016 ACR/ARHP Annual Meeting
Maintenance of Improvements in Patients’ Physical Function, Workplace and Household Productivity, and Reduction in Caregiver Burden with 2 Years of Certolizumab Pegol Treatment in DMARD-Naive, Early RA Patients with Severe Progressive Disease
Clifton Bingham III¹, Paul Emery², Michael Weinblatt³, Gerd-Rüdiger Burmester⁴, Daniel E. Furst⁵, Xavier Mariette⁶, Ronald van Vollenhoven⁷, Brenda VanLunen⁸, Oana Purcaru⁹ and Vivian P. Bykerk¹⁰, ¹Johns Hopkins University, Baltimore, MD, ²University of Leeds, Leeds, United Kingdom, ³Brigham and Women’s Hospital, Boston, MA, ⁴Charité – University Medicine Berlin, Berlin, Germany, ⁵David Geffen School of Medicine at UCLA, Los Angeles, CA, ⁶Université Paris-Sud, Paris, France, ⁷Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands, ⁸UCB Pharma, Raleigh, NC, ⁹UCB Pharma, Slough, United Kingdom, ¹⁰Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Rheumatoid arthritis (RA) is associated with loss of physical function, work disability, and decreased quality of life. Early treatment with certolizumab pegol (CZP) in…
Abstract Number: 2973 • 2016 ACR/ARHP Annual Meeting
A Comparison of Caregiving Burden and Impact in Systemic Vasculitis Versus Other Conditions
Matthew Gray¹, Delesha M. Carpenter², Lorie L. Geryk³, Courtney A. Roberts⁴, Joshua M. Thorpe⁵, Tao Jiang⁵, Susan L Hogan⁶ and Carolyn T. Thorpe⁵, ¹University of Pittsburgh, Pittsburgh, PA, ²Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Asheville, NC, ³Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Chapel Hill, NC, ⁴Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ⁵School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, ⁶UNC Kidney Center, Chapel Hill, NC
Background/Purpose: Serving as an informal caregiver to a family member or friend with a chronic illness is associated with stress, reduced health status, and financial…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].